CARE Ratings has reaffirmed Bhageria Industries' credit rating at CARE A/A1 and removed it from 'Rating Watch with Negative Implications,' assigning a 'Stable' outlook. This upgrade follows the company's receipt of restart permission from the Maharashtra Pollution Control Board for its H-acid manufacturing unit, easing previous operational uncertainties. The total rated bank facility now stands at Rs 141 crore.
Bhageria Industries Credit Rating Outlook Revised to Stable
Total Rated Amount: Rs 141 crore. Rating Action: Removal from Rating Watch with Negative Implications.
Reader Takeaway: Regulatory clearance for H-acid unit operations removes a major uncertainty, stabilizing the company's credit risk profile.
What just happened
CARE Ratings Limited has reaffirmed Bhageria Industries’ bank facilities at 'CARE A; Stable / CARE A1'. Most importantly, the agency has removed the 'Rating Watch with Negative Implications' tag that had previously clouded the company’s outlook. The ratings now carry a 'Stable' outlook, reflecting improved confidence in the firm’s operational continuity.
Why this matters
The 'Rating Watch' status typically alerts investors to specific risks that could lead to a downgrade. By lifting this status, CARE Ratings indicates that the immediate regulatory risks linked to the company's manufacturing operations have been resolved. This move provides better visibility to lenders and investors regarding the company's debt-servicing capability.
The backstory
The rating committee’s decision was largely driven by the company securing official restart permissions from the Maharashtra Pollution Control Board (MPCB). This approval pertains specifically to the sulphonation section of the firm's H-acid manufacturing unit, which had previously faced operational restrictions. The rating action also reflects a review of the company's audited FY26 and unaudited Q1FY27 financial performance.
What changes now
The company’s rated debt capacity has been enhanced to Rs 141 crore from the previous Rs 91 crore. This facility is backed by a consortium of lenders including Yes Bank, Axis Bank, and Kotak Mahindra Bank, with the majority of the limit (Rs 140 crore) classified as fund-based.
What to track next
Investors should monitor the company’s ability to maintain full-scale production at the H-acid unit without further regulatory interruptions. Future financial filings will be key to seeing if this operational recovery translates into stronger margin growth in the coming quarters.